CRDFCardiff Oncology, Inc.

$137M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$313,000+11.8% YoY

Gross Profit

-$316,000-101.0% margin

Operating Income

-$25M-8074.8% margin

Net Income

-$27M-8776.7% margin

EPS (Diluted)

$-74.77

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$24M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$71M

Total Liabilities

$23M

Stockholders' Equity

$49M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$313,000	$280,000	+11.8%
Gross Profit	-$316,000	$265,000	-219.2%
Operating Income	-$25M	-$15M	-69.1%
Net Income	-$27M	-$14M	-91.8%

CRDF FY 2015 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena